ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 717859 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 717859; 2) Community: the network communities that were significantly associated with the response to NSC 717859; 3) Molecule: the relationships between components within communities and NSC 717859; 4) MDR: the compounds that were significantly associated with the NSC 717859.

NSC Compound Enrichment Correlation
NSC 723397 Null 0.00957309511256283 0.0475485
NSC 732568 6,8-Dibromo-2-phenyl-3-[5?-amino6?(2??,3??-dichlorophenyl)1, 2,4-triazin-3-yl]quinazolin-4(3H)-one (SPC-IIIBr) 0.00957309511256283 0.021644467
NSC 764043 (+)-JQ1 0.00957309511256283 -0.10464864
NSC 682436 Naphth[2,3-d]oxazol-9(4H)-one, 4-[(2-aminocyclohexyl) imino]-2-methyl-, acetate 0.00995118568011482 -0.26365166
NSC 166382 Null 0.0105244982742819 -0.15240451
NSC 18805 .gamma.-Thujaplicine 0.0105244982742819 -0.14574348
NSC 45236 Null 0.0105244982742819 0.015139063
NSC 606497 Camptothecin Derivative 0.0105244982742819 -0.014469084
NSC 681632 Camptothecin Derivative 0.0105244982742819 0.049928413
NSC 681633 Camptothecin Derivative 0.0105244982742819 -0.059660508
Total:57  Current:14    [First] [Prev] [Next] [Last]